Accuracy of serological tests in diagnosing mucosal leishmaniasis
Parasitology Research · 2023
DOI: 10.1007/s00436-023-07900-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Parasitology Research, 2023. Verfasst von Diana Oliveira und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research and Public Politics in Infectious and Parasitic Diseases, Instituto René Rachou, Oswaldo Cruz Foundation, Belo Horizonte, Minas Ger…. Hauptthemen laut MEDLINE: Leishmaniasis, Visceral, Leishmania. Die Arbeit nennt 52 Literaturangaben.
Abstract (Originalsprache)
In this serum panel-based study, we evaluated the accuracy of serological tests originally developed for visceral leishmaniasis (VL), for diagnosis of mucosal leishmaniasis (ML). A total of five tests were evaluated, four of which are registered at the National Agency of Sanitary Surveillance (Agência Nacional de Vigilância Sanitária-ANVISA) (RIDASCREEN® Leishmania Ab from R-Biopharm AG., Leishmania ELISA IgG + IgM from Vircell S.L., IFI Leishmaniose Humana-BioManguinhos, and IT-LEISH® from Bio-Rad Laboratories, Inc.), and the other a direct agglutination test (DAT-LPC) prototype kit developed at Fiocruz. The panel was composed of 40 serum samples from patients with confirmed ML and 20 from patients with mucosal involvement and negative parasitological/molecular tests for leishmaniasis and confirmation of another etiology. All cases were treated from 2009 to 2016 in a referral center for leishmaniasis in Belo Horizonte, Minas Gerais, Brazil (Instituto René Rachou, Fiocruz). Diagnostic accuracy, based on the cut-off point for VL diagnosis, was 86.2% with RIDASCREEN® Leishmania Ab, 73.3% with Leishmania ELISA IgG + IgM, and 66.7% with IFI Leishmaniose Humana, while IT-LEISH® and DAT-LPC had the lowest accuracy (38.3%), despite high specificity (100% and 95%, respectively). New cut-off points defined with sera from ML patients improved accuracy from 86.2 to 89% (p = 0.64) and 73.3 to 88% (p = 0.04) for RIDASCREEN® Leishmania Ab and Leishmania ELISA IgG + IgM, respectively. Moreover, these tests presented greater sensitivity and immunoreactivity in patients with moderate/severe clinical ML forms. The data of this study suggest that ELISA assays can contribute to laboratory diagnosis, especially for patients with moderate or severe mucosal involvement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research and Public Politics in Infectious and Parasitic Diseases, Instituto René Rachou, Oswaldo Cruz Foundation, Belo Horizonte, Minas Gerais, Brazil.
- Clinical Research and Public Politics in Infectious and Parasitic Diseases, Instituto René Rachou, Oswaldo Cruz Foundation, Belo Horizonte, Minas Gerais, Brazil. glaucia.cota@fiocruz.br.
- Clinical Research and Public Politics in Infectious and Parasitic Diseases, Instituto René Rachou, Oswaldo Cruz Foundation, Belo Horizonte, Minas Gerais, Brazil. edward.oliveira@fiocruz.br.
Zitieren
APA
Oliveira, D., Lopes, K. F., de Avelar, D. M., Cota, G., & Oliveira, E. (2023). Accuracy of serological tests in diagnosing mucosal leishmaniasis. Parasitology Research. https://doi.org/10.1007/s00436-023-07900-9
Vancouver
Oliveira D, Lopes KF, de Avelar DM, Cota G, Oliveira E. Accuracy of serological tests in diagnosing mucosal leishmaniasis. Parasitology Research. 2023. doi:10.1007/s00436-023-07900-9
BibTeX
@article{Oliveira2023,
author = {Oliveira, Diana and Lopes, Karine Ferreira and de Avelar, Daniel Moreira and Cota, Gláucia and Oliveira, Edward},
title = {Accuracy of serological tests in diagnosing mucosal leishmaniasis},
journal = {Parasitology Research},
year = {2023},
doi = {10.1007/s00436-023-07900-9}
}
EUVIMED